Related Experiment Video
Updated: Jun 26, 2025

Assays for the Identification of Novel Antivirals against Bluetongue Virus
Published on: October 11, 2013
Lectibodies as antivirals
Ian Carlosalberto Santisteban Celis1, Nobuyuki Matoba2
1Department of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, KY, USA; Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases, University of Louisville School of Medicine, Louisville, KY, USA.
New recombinant lectin-Fc fusion proteins, or lectibodies, offer a promising strategy to overcome the limitations of natural lectins for developing effective antiviral therapeutics against emerging viral diseases.
Area of Science:
- Virology
- Biochemistry
- Immunology
Background:
- Emerging viral diseases necessitate novel antiviral therapeutics.
- Enveloped viruses present surface glycans that are potential therapeutic targets.
- Natural lectins show antiviral activity but have limitations for pharmaceutical use.
Purpose of the Study:
- To review the rationale for lectin-based antiviral strategies.
- To explore recombinant lectin-Fc fusion proteins (lectibodies) as improved antiviral agents.
- To discuss the broader potential of lectibodies beyond antiviral applications.
Main Methods:
- Review of existing literature on lectins and antiviral strategies.
- Discussion of the design and potential advantages of lectibodies.
- Exploration of the pharmacological properties and manufacturing considerations for lectibodies.
Main Results:
- Natural lectins possess antiviral properties but exhibit toxicity and manufacturing challenges.
- Recombinant lectibody technology offers a method to enhance lectin suitability for therapeutic use.
- Lectibodies may provide improved efficacy, safety, and manufacturability compared to natural lectins.
Conclusions:
- Lectibodies represent a promising platform for developing novel antiviral therapeutics.
- This approach addresses key limitations of natural lectins for pharmaceutical development.
- Lectibodies hold potential for applications beyond antiviral therapies.
More Related Videos
Related Concept Videos
Retrovirus Life Cycles
Retroviruses
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

